🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of intravenous RC48-ADC co...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
Start Date
2022-11-23
Trial ID
NCT05917158
Treatments Being Tested
This study is a prospective, open-label, phase II clinical trial that aims ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-01
Trial ID
NCT06385873
Treatments Being Tested
This study is a one-arm exploratory clinical study of Disitamab Vedotin for...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-01
Trial ID
NCT05488353
Treatments Being Tested
This is a prospective, multicenter, phase II study designed to evaluate the...
Status
Recruiting
Location
Jiangsu Cancer Hospital
Start Date
2026-01-01
Trial ID
NCT07311577
Treatments Being Tested
Objectives: To evaluate the non-inferiority of disitamab vedotin plus gemci...
Status
Recruiting
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2026-07-01
Trial ID
NCT07693959
Treatments Being Tested
This is a prospective, open, multiple-center clinical study of renal preser...
Status
Recruiting
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2023-06-10
Trial ID
NCT05912816
Treatments Being Tested
This is a prospective, open, single-center clinical study of anti-HER2-ADC ...
Status
Unknown
Location
Ethics Committee of Shanghai Renji Hospital
Start Date
2023-08-05
Trial ID
NCT05957757
Treatments Being Tested
This is a single-arm, open-label, Phase Ib/II clinical trial designed to ev...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-04-30
Trial ID
NCT06957561
The purpose of this study is to evaluate the efficacy and safety of Disitam...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-11-28
Trial ID
NCT06178159
Treatments Being Tested
It is a single arm, open-label, phase II cinical trial to evaluate the effi...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2023-05-01
Trial ID
NCT06383533
Treatments Being Tested